The impact of vibration on microscopy
In this interview, Industry expert Brian Keith disucsses the impact of vibration on microscopy, from the common sources…
Anti-dumping tariffs: Australia targets cut-price Chinese steel and windows
Australia is fighting back with targeted penalties for Chinese companies who sell steel and aluminium windows at a…
Back Australia: 73% fear reliance on overseas goods and services
South Australia has a proud history and bright future of building the industries that define our nation. The…
Pearson, WorldSkills Australia partner to strengthen skilled workforce pipeline
Stock image. Image credit: tong2530/stock.adobe.com Pearson and WorldSkills Australia have announced a new partnership to strengthen vocational training…
Back Australia: How Aussies reshaped the economy in a year
When the Herald Sun and other News Corp Australia mastheads launched the Back Australia campaign a year ago…
Estonia industrial output jumps 4.5% in August on energy surge | News
Estonia’s industrial production rose 4.5 percent year on year in August, with output up in all three sectors…
September NPD launchpad: Beauty, peptides, and convenient formats
Nourished launches sleep support gummy Personalized nutrition brand Nourished has launched Sleep Pro – a sleep support gummy…
Beyond fins, Japanese firms seeking new values in sharks
Fins may be the best-known part of a shark to food lovers, but Japanese companies are trying to…
Why scientists still cannot say how much plastic infants are actually consuming
From feeding bottles to formula and breast milk, researchers traced where plastic particles and oligomers appear and why…
Submicron IR for pharmaceutical research, development, and quality
The pharmaceutical and biopharmaceutical industries increasingly require rapid, accurate, and high-resolution analytical tools to characterize complex materials, ensure…
New partnership to strengthen CAR-T cell therapy manufacturing capabilities in Japan
Cell and gene therapies, including CAR-T cell therapies, are expected to become increasingly important treatment options for cancer…
EpilepsyGTx and Viralgen collaborate to advance AAV gene therapy program for epilepsy ahead of first-in-human trial
EpilepsyGTx, a biotechnology company developing gene therapies for refractory epilepsy, and Viralgen, a leading contract development and manufacturing…